4
The impact of hemi-brain irradiation on accumulation of PI3K/mTOR inhibitors with limited (GDC-0980) and robust (GNE-317) blood-brain barrier penetration Digital Poster Discussion Session (DPD 08) Biology 2 - Head/Neck and CNS Tumors (#11) TT Sio 1 , RK Oberoi 2 , MP Grams 1 , KM Furutani 1 , SK Gupta 1 , ZC Wilson 1 , JL Pokorny 1 , DO Iyekegbe Jr. 1 , KK Bakken 1 , MA Schroeder, BL Carlson 1 , K Chang 1 , WF Elmquist 2 , JN Sarkaria 1 1 Department of Radiation Oncology, Mayo Clinic, Rochester, MN; 2 Department of Pharmaceutics, University of Minnesota, Minneapolis, MN

The impact of hemi-brain irradiation on accumulation of PI3K/mTOR inhibitors with limited (GDC-0980) and robust (GNE-317) blood-brain barrier penetration

Embed Size (px)

Citation preview

Page 1: The impact of hemi-brain irradiation on accumulation of PI3K/mTOR inhibitors with limited (GDC-0980) and robust (GNE-317) blood-brain barrier penetration

The impact of hemi-brain irradiation on accumulation of PI3K/mTOR inhibitors with limited (GDC-0980) and robust (GNE-317) blood-brain barrier penetrationDigital Poster Discussion Session (DPD 08) Biology 2 - Head/Neck and CNS Tumors (#11)

TT Sio1, RK Oberoi2, MP Grams1, KM Furutani1, SK Gupta1, ZC Wilson1, JL Pokorny1, DO Iyekegbe Jr.1, KK Bakken1, MA Schroeder, BL Carlson1, K Chang1, WF Elmquist2, JN Sarkaria1

1Department of Radiation Oncology, Mayo Clinic, Rochester, MN; 2Department of Pharmaceutics, University of Minnesota, Minneapolis, MN

Page 2: The impact of hemi-brain irradiation on accumulation of PI3K/mTOR inhibitors with limited (GDC-0980) and robust (GNE-317) blood-brain barrier penetration

Introduction• Commonly believed that RT can improve penetration of small

molecules into brain and tumors• However, this has not been quantitatively established

Methods• C57BL/6 mice were treated with hemi-brain irradiation

– By a tungsten collimated high-dose-rate 192Ir beam

• Experiment 1: One group of mice was irradiated with 40 Gy in a single fraction and euthanized up to 160 hours later

• Experiment 2: Mice were treated with 4 Gy x10 fractions, and euthanized up to 6 weeks after the end of RT

• All mice were orally dosed with GNE-317 (30 mg/kg) and GDC-0980 (7.5 mg/kg) concomitantly 1 hr before euthanasia, and irradiated and unirradiated brain hemispheres and plasma were collected

• Drug concentrations in both hemispheres and plasma were assessed by mass spectrometry

Page 3: The impact of hemi-brain irradiation on accumulation of PI3K/mTOR inhibitors with limited (GDC-0980) and robust (GNE-317) blood-brain barrier penetration

Results

• Consistent with previous data, the mean ± SD brain-to-plasma ratio for GNE-317 and GDC-0980 in unirradiated brain for all animals was 0.91 ± 0.23 and 0.048 ± 0.018, respectively

• For drug levels in the irradiated brains, the brain-to-plasma ratio for the 2 drugs was 1.01 ± 0.27 and 0.054 ± 0.020.

• To readily compare the effects of radiation on drug accumulation at each time-point, the drug levels in unirradiated vs. irradiated brain were compared by a paired t-test– No significant difference in accumulation of GNE-317 or

GDC-0980 associated with irradiation at any of the time-points investigated

Page 4: The impact of hemi-brain irradiation on accumulation of PI3K/mTOR inhibitors with limited (GDC-0980) and robust (GNE-317) blood-brain barrier penetration

• Neither fractionated nor single-dose RT had significant impact on the accumulation of either GNE-317 or GDC-0980 in the brain

• Specifically, RT did not significantly increase the penetration of the brain-impenetrant GDC-0980 compound

• Further experiments investigating the effect of RT on the blood-brain-tumor-barrier are currently ongoing